Ireland
--:--IST
Latest
Clinical Trials in France / NCT07622095
Recruiting Observational

Validation of the French Version of the New Mobility Score (NMS)

NCT07622095 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2026-08-27
Last updated
2026-09-03

Condition(s) studied

Hip FracturesMobility LimitationIndependenceAutonomy

Investigational drug(s) / intervention(s)

Questionnaires

Questionnaires: New Mobility Score (NMS), Measure of Functional Independence (MIF), Cumulated Ambulation Score (CAS), Mini-Mental State Examination (MMSE).

Study summary

The incidence of hip fractures in France is 50,000 cases per year among women and 16,000 among men, with a 1-year mortality rate of 20-24%. After a fracture, 10-30% of patients become functionally dependent. The increasing aging of the population and the rise in dependency are likely to worsen the situation of older patients in hospital settings.

Several tools are available to assess functional independence, including the New Mobility Score (NMS), which evaluates mobility through three domains: mobility indoors, mobility outdoors, and shopping activities. The NMS has shown good performance in predicting patient mortality and functional recovery, and its use is recommended in clinical practice. However, the French version of the NMS has not yet been validated.

The French validation of the NMS is important to facilitate its implementation in clinical practice and research, particularly because of its simplicity and the need for rapid assessment tools for healthcare professionals. A French version of the NMS has been translated, and the MOB-SCORE study aims to assess its reliability and validity among healthcare professionals caring for patients with hip fractures.

Eligibility

Sex
ALL
Min age
75 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients aged 75 years and older admitted to a hospital department following a hip fracture and treated surgically (osteosynthesis or arthroplasty). * Type of fracture: pertrochanteric fracture or femoral neck fracture. * Sufficient proficiency in French to complete the questionnaires. * Patients affiliated with a health insurance scheme. * No objection to participate from the patient or the caregiver in case of cognitive impairment. Exclusion Criteria: no exclusion criteria

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Service I3 de court séjour gériatrique, Hôpital de la Croix-Rousse, Hospices Civils de Lyon Lyon France Recruiting

More Hospices Civils de Lyon trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07622095 on ClinicalTrials.gov ↗ ← All trials in France